Is a complete TRAW research report available?

No complete published report is available for Traws Pharma, Inc. (TRAW) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Traws Pharma, Inc. (TRAW)

NASDAQ: TRAW · USD

$0.52

-0.02 (-4.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TRAW analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	7.9M
Revenue (ttm)	2.7M
Net income (ttm)	-13.9M
EPS (ttm)	-$1.52
Shares out	15.2M
Volume	82,964
Beta	1.51
Price target	$1.00	+92.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.7M
Net income (ttm): -13.9M
EPS (ttm): -$1.52
Market cap: 7.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TRAW indicators

Market & fundamental data

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001130598
Company name	Traws Pharma, Inc.
Country	United States
Country code	US
Cusip	68232V884
Employees	7
Employees Change	-11%
Employees Change Percent	-61.11
Enterprise value	$4.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-07-25
Isin	US68232V8845
Last refreshed	2026-07-24
Market cap	$7.9M
Market cap category	Nano-Cap
Price	$0.52
Price currency	USD
Rev Per Employee	390,428.57x
Sector	Healthcare
Sector PE	44.54
Sector PE Fwd	23.46
Sic	2834
Symbol	TRAW
Website	https://www.trawspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-173.23%
EV/Sales	1.79x
FCF yield	-190.84%
P/S ratio	2.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-717.82%
EBITDA Margin	-714.01%
Gross margin	100%
Gross Profit	$2.7M
Gross Profit Growth	1,103.96%
Gross Profit Growth3 Y	129.53%
Gross Profit Growth5 Y	63.35%
Net Income	$-13.9M
Net Income Growth Years	1%
Pretax Margin	-710.83%
Profit Per Employee	$-2M
Profitable Years	1
ROA	-90.09
Roa5y	-44.45
ROCE	388.3
ROE	-5,639.2
ROIC	-3,559.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-66.1%
Cagr1y	-67.93%
Cagr3y	-72.93%
Cagr5y	-67.12%
EPS Growth Years	1
Revenue Growth	1,103.97x
Revenue Growth Years	1x
Revenue Growth3 Y	129.53x
Revenue Growth5 Y	63.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.2
Assets	$8.2M
Cash	$3.1M
Current Assets	$5.7M
Current Liabilities	$13.2M
Debt	$0
Equity	$-5.3M
Liabilities	$13.5M
Long Term Assets	$2.5M
Long Term Liabilities	$259,000
Net Cash	$3.1M
Net Cash By Market Cap	$39.02
Net Cash Growth	-80.34%
Tangible Book Value	$-7.8M
Tangible Book Value Per Share	$-0.77
WACC	12.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.43
Net Working Capital	$-10.7M
Quick ratio	0.36
Working Capital	$-7.5M
Working Capital Turnover	$5.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-196.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-67.9%
200-day SMA	1.74
3Y total return	-98.02%
50-day SMA	1.09
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.62%
All Time High	1,751,060.3
All Time High Change	-100%
All Time High Date	2013-10-04
All Time Low	0.52
All Time Low Change	0%
All Time Low Date	2026-07-23
ATR	0.08
Beta	1.51
Beta1y	-0.39
Beta2y	0.33
Ch YTD	-53.98
High	0.54
High52	3.27
High52 Date	2025-10-10
High52ch	-84.07%
Low	0.52
Low52	0.52
Low52 Date	2026-07-23
Low52ch	0%
Ma50ch	-52.38%
Premarket Change Percent	0.39
Premarket Price	$0.54
Premarket Volume	7,272
Price vs 200-day SMA	-70.05%
RSI	26.72
RSI Monthly	27.07
RSI Weekly	34.45
Sharpe ratio	-0.25x
Sortino ratio	-0.31
Total Return	-196.62%
Tr YTD	-53.98
Tr1m	-41.69%
Tr1w	-21.69%
Tr3m	-59.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.4
Operating Income	$-19.6M
Operating margin	-717.8
Price target	$1
Price Target Change	$92.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,726,055%
Float Percent	77.4%
Shares Insiders	5.48%
Shares Institutions	29.25%
Shares Out	15,150,669
Shares Qo Q	13.7%
Shares Yo Y	196.62%
Short Float	8.36%
Short Ratio	1.81
Short Shares	6.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-16.5M
Average Volume	163,412.7x
Bv Per Share	-0.52
Ch10y	-100
Ch1m	-41.69
Ch1w	-21.69
Ch1y	-67.9
Ch3m	-59.69
Ch3y	-98.02
Ch5y	-99.62
Ch6m	-79.12
Change	-4.11%
Change From Open	-3.53
Close	0.54
Days Gap	-0.61
Depreciation Amortization	104,000
Dollar Volume	43,141.3
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-19.6M
EBITDA	$-19.5M
EPS	$-1.52
F Score	1
FCF	$-15.3M
FCF EV Yield	-312.94x
FCF Per Share	$-1.01
Financing CF	5,088,000
Fiscal Year End	December
Founded	1,998
Investing CF	-2,585,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-09-23
Last Split Type	Reverse
Last10k Filing Date	2026-04-15
Ma150	1.5
Ma150ch	-65.38%
Ma20	0.71
Ma20ch	-26.41%
Net CF	-12,804,000
Next Earnings Date	2026-08-13
Open	0.54
Optionable	No
Position In Range	0
Post Close	0.52
Postmarket Change Percent	0.19
Postmarket Price	$0.52
Ppne	6,000
Pre Close	0.54
Price Date	2026-07-23
Relative Volume	0.51x
Revenue	2,733,000x
SBC By Revenue	43.94x
Share Based Comp	1,201,000
Tr6m	-79.12%
Us State	Pennsylvania
Volume	82,964
Z Score	-119.2

Traws Pharma, Inc. (TRAW)

Coverage state: Market snapshot only — no published research

Generate the first TRAW analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TRAW

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TRAW indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TRAW

Frequently asked questions